Trial Profile
Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat
- Indications Hepatitis C
- Focus Therapeutic Use
- 03 Aug 2016 Status changed from recruiting to completed.
- 23 Aug 2014 New trial record